Akero Therapeutics Shares Plummet Premarket After NASH Study Update Markets – MarketWatch
Posted on by
By Colin Kellaher Shares of Akero Therapeutics plunged in premarket trading Tuesday after the biotechnology company gave an interim update on a Phase 2b…